Health-related quality of life with lenvatinib in combination with everolimus
Maintaining good health-related quality of life is important for all [...]
Maintaining good health-related quality of life is important for all [...]
At the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
This phase 2 clinical trial (ENTRATA) looked at how safe [...]
This phase 1 clinical trial looked at the safety, tolerability, [...]
Results from the phase 3 CLEAR study, presented at the [...]
Treating non-clear cell renal cell carcinoma (RCC) is challenging because [...]
In this phase 2 clinical trial, a combination of everolimus [...]
A new combination of vorolanib, a tyrosine kinase inhibitor plus [...]
A randomised clinical trial of hypoxia inducible factor 2α (HIF-2α) [...]
Five-year follow-up results from the phase 3 CheckMate-025 study, which [...]